Rituximab-Based Regimen As First-Line Treatment in Chinese Patients with Follicular Lymphoma: Three-Year Safety Data from a Prospective, Observational Study

被引：0
|
作者：
Wu, Jianqiu
Song, Yongping
Su, Liping
Zhang, Mingzhi
Li, Wei
Hu, Yu
Zhang, Xiaohong
Gao, Yuhuan
Niu, Zuoxing
Feng, Ru
Wang, Wei
Peng, Jiewen
Li, Xiaolin
Ouyang, Xuenong
Wu, Changping
Zhang, Weijing
Zeng, Yun
Xiao, Zhen
Liang, Yingmin
Zhuang, Yongzhi
Wang, Jishi
Sun, Zimin
Bai, Hai
Cui, Tongjian
Feng, Jifeng
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5167
引用
收藏
页数：2
相关论文
共 50 条
  • [31] NICE guidance on rituximab for first-line treatment of symptomatic stage III-IV follicular lymphoma in previously untreated patients
    Doss, Sally
    Garrett, Zoe
    Sutcliffe, Frances
    Stevens, Andrew
    LANCET ONCOLOGY, 2012, 13 (02): : 128 - 130
  • [32] Rituximab as first-line treatment of patients with follicular lymphoma (FL) and a low-burden tumor: Clinical and molecular evaluation.
    Solal-Celigny, P
    Salles, G
    Brousse, N
    Eftekhari, P
    Soubeyran, P
    Lacotte, L
    Deconinck, E
    Haioun, C
    Foussard, C
    Sebban, C
    Stamatoulas, A
    Milpied, N
    Boue, F
    Taillan, B
    Lederlin, P
    Najman, A
    Mathieu-Boue, A
    Benzohra, A
    Colombat, P
    BLOOD, 1999, 94 (10) : 631A - 631A
  • [33] Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study
    Garcia-Munoz, Ricardo
    Quero, Cristina
    Perez-Persona, Ernesto
    Domingo-Garcia, Abel
    Perez-Lopez, Cristina
    Villaescusa-de-la-Rosa, Teresa
    Martinez-Castro, Ana M.
    Arguinano-Perez, Jose M.
    Parra-Cuadrado, Juan F.
    Panizo, Carlos
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (05) : 661 - 673
  • [34] A multicenter randomized trial of Fludarabine and Mitoxantrone (FM) plus Rituximab versus CHOP plus Rituximab as first-line treatment in patients with follicular lymphoma (FL).
    Zinzani, PL
    BLOOD, 2002, 100 (11) : 93A - 93A
  • [35] A pilot study on the use of the ProMACE CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma
    Baldini, L
    Guffanti, A
    Gobbi, P
    Colombi, M
    Federico, M
    Avanzini, P
    Cavanna, L
    Pieresca, C
    Silingardi, V
    Maiolo, AT
    CANCER, 1997, 79 (06) : 1234 - 1240
  • [36] EFFICACY AND SAFETY OF BENDAMUSTINE IN ASSOCIATION WITH RITUXIMAB AS FIRST-LINE TREATMENT FOR PATIENTS WITH INDOLENT NON-HODGKIN LYMPHOMA OR MANTLE CELL LYMPHOMA
    Cencini, E.
    Fabbri, A.
    Iannuzzi, A.
    Schiattone, L.
    Brambilla, C. Zuanelli
    Bocchia, M.
    HAEMATOLOGICA, 2017, 102 : 112 - 112
  • [37] PERSPECTIVE: A Randomized, Phase 3 Study of Ibrutinib-Rituximab Versus Placebo-Rituximab Combination Therapy for First-Line Treatment of Follicular Lymphoma
    Flinn, Ian
    Gordon, Leo
    Rule, Simon
    Chen, Robert
    Kwei, Long
    Chu, Alvina
    Fowler, Nathan
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 : S12 - S13
  • [38] Bendamustine plus Rituximab Versus R-CHOP as First-Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study
    Mondello, Patrizia
    Steiner, Normann
    Willenbacher, Wolfgang
    Cerchione, Claudio
    Nappi, Davide
    Mauro, Endri
    Ferrero, Simone
    Cuzzocrea, Salvatore
    Mian, Michael
    ONCOLOGIST, 2018, 23 (04): : 454 - 460
  • [39] Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy
    Leich, E.
    Brodtkorb, Marianne
    Schmidt, T.
    Altenbuchinger, M.
    Lingjaerde, Ole Christian
    Lockmer, S.
    Holte, H.
    Nedeva, T.
    Grieb, T.
    Sander, B.
    Sundstroem, C.
    Spang, R.
    Kimby, E.
    Rosenwald, A.
    LEUKEMIA & LYMPHOMA, 2023, 64 (12) : 1927 - 1937
  • [40] Obinutuzumab Versus Rituximab Based First-Line Chemoimmunotherapy for Follicular Lymphoma - a Real-World Multicenter Retrospective Cohort Study
    Berger, Tamar
    Shochat, Tzippy
    Aumann, Shlomzion
    Nachmias, Boaz
    Goldschmidt, Neta
    Horesh, Nurit
    Harel, Reut
    Aviv, Ariel
    Shmerts, Ella
    Abadi, Uri
    Raanani, Pia
    Gafter-Gvili, Anat
    Gurion, Ronit
    BLOOD, 2022, 140 : 11947 - 11948
12345